Wolf M, Ewen S, Mahfoud F, Bohm M
Clin Res Cardiol. 2018; 107(Suppl 2):16-29.
PMID: 29951800
DOI: 10.1007/s00392-018-1299-y.
Prichard B, Johnston A, Hill I, ROSENHEIM M
Br Med J. 2010; 1(5585):135-44.
PMID: 20791420
PMC: 1984601.
DOI: 10.1136/bmj.1.5585.135.
Kopin I, Fischer J, MUSACCHIO J, HORST W
Proc Natl Acad Sci U S A. 1964; 52:716-21.
PMID: 14212547
PMC: 300335.
DOI: 10.1073/pnas.52.3.716.
Chamberlain D, Howard J
Br Heart J. 1964; 26:528-36.
PMID: 14196136
PMC: 1018172.
DOI: 10.1136/hrt.26.4.528.
DAY M, Rand M
Br J Pharmacol Chemother. 1964; 22:72-86.
PMID: 14126060
PMC: 1703913.
DOI: 10.1111/j.1476-5381.1964.tb01545.x.
EFFECT OF ALPHA-METHYL-DOPA ON MYOCARDIAL CATECHOLAMINES.
Maitre L, STAEHELIN M
Experientia. 1963; 19:573-5.
PMID: 14101511
DOI: 10.1007/BF02150996.
Disposition and pharmacodynamics of diuretics and antihypertensive agents in renal disease.
Mirkin B, Green T, ODea R
Eur J Clin Pharmacol. 1980; 18(1):109-16.
PMID: 7398740
DOI: 10.1007/BF00561487.
A study of central adrenergic mechanisms in the regulation of the oestrous cycle of albino mice.
Bhargava K, Gupta M
Br J Pharmacol Chemother. 1966; 26(3):601-5.
PMID: 6006300
PMC: 1510698.
DOI: 10.1111/j.1476-5381.1966.tb01840.x.
[Demonstration of alpha-methylnoradrenaline in the urine of hypertensive patients treated with alpha-methyldopa].
Muscholl E, Rahn K
Klin Wochenschr. 1966; 44(24):1412-3.
PMID: 5994691
DOI: 10.1007/BF01752485.
The effect of stimulation of sympathetic nerves in the cat treated with reserpine, alpha-methyldopa and alpha-methylmetatyrosine.
Haefely W, Hurlimann A, Thoenen H
Br J Pharmacol Chemother. 1966; 26(1):172-85.
PMID: 5920649
PMC: 1510766.
DOI: 10.1111/j.1476-5381.1966.tb01819.x.
[The effect of the administration of amino acids, especially of L-dopa and alpha-methyldopa, on the composition of cerebrospinal fluid in extrapyramidal syndromes. II. Alterations of cerebrospinal fluid in patients with Parkinson's disease and...].
GRUNDIG E, Gerstenbrand F, Bruck J, Gnad H, PROSENZ P, Simanyi M
Dtsch Z Nervenheilkd. 1969; 196(3):256-65.
PMID: 5820717
Variation in the modification of cardiovascular responses by sympathetic inhibitory drugs.
Prichard B
Proc R Soc Med. 1969; 62(1):84-91.
PMID: 5763482
PMC: 2279028.
Effects of alpha-methyl-dopa on conditioned behaviour in the cat.
Hanson L, Henning M
Psychopharmacologia. 1967; 11(1):1-7.
PMID: 5596861
DOI: 10.1007/BF00401503.
Actions of noradrenaline, other sympathomimetic amines and antagonists on neurones in the brain stem of the cat.
Boakes R, Bradley P, Brookes N, Candy J, Wolstencroft J
Br J Pharmacol. 1971; 41(3):462-79.
PMID: 5576254
PMC: 1702877.
DOI: 10.1111/j.1476-5381.1971.tb08044.x.
An investigation of alpha-methyl amino-acids and their derivatives on isolated tissue preparations.
Gulati O, PARIKH H, Ringe S, Sherlekar M
Br J Pharmacol. 1970; 40(4):689-701.
PMID: 5495174
PMC: 1702915.
DOI: 10.1111/j.1476-5381.1970.tb10647.x.
Mechanism of the hypotensive action of methyldopa in normal and immunosympathectomized rats.
Varma D
Br J Pharmacol. 1970; 40(2):186-93.
PMID: 5492891
PMC: 1702886.
DOI: 10.1111/j.1476-5381.1970.tb09912.x.
Blockade of biogenic amine synthesis: its effect on the responses to leptazol and dexamphetamine in rats.
Spencer P, TURNER T
Br J Pharmacol. 1969; 37(1):94-103.
PMID: 5343360
PMC: 1703769.
DOI: 10.1111/j.1476-5381.1969.tb09526.x.
Recent advances in the treatment of hypertension.
Smith W
Calif Med. 1966; 105(5):371-6.
PMID: 5334339
PMC: 1516570.
A possible relationship between catecholamines and acute toxicity of desipramine.
Lal H, Brown R
Psychopharmacologia. 1968; 12(4):354-7.
PMID: 5301232
DOI: 10.1007/BF00401414.
The mode of action of -methyldopa.
DAY M, Roach A, Whiting R
Br J Pharmacol. 1972; 45(1):168P-169P.
PMID: 5041485
PMC: 1666180.
